Neonatal Drug Development Could Benefit From Rare Disease Experience

Early parent involvement in drug development and clinical trial design could improve recruitment and outcomes, stakeholders argue.

Neonatal ICU
Parents may be more interested in therapies that could help babies leave the NICU sooner, rather than an improvement in a clinical score. • Source: Shutterstock

More from R&D

More from Pink Sheet